Ephedrine activates brown adipose tissue in lean but not obese humans von Carey, A. L., Formosa, M. F., Van Every, B., Bertovic, D., Eikelis, N., Lambert, G. W., Kalff, V., Duffy, S. J., Cherk, M. H., Kingwell, B. A.

Volltext

Concordance among gene expression-based predictors for ER-positive breast cancer treated with adjuvant tamoxifen von Prat, A., Parker, J.S., Fan, C., Cheang, M.C.U., Miller, L.D., Bergh, J., Chia, S.K.L., Bernard, P.S., Nielsen, T.O., Ellis, M.J., Carey, L.A., Perou, C.M.

Volltext

Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up von Loibl, S., André, F., Bachelot, T., Barrios, C.H., Bergh, J., Burstein, H.J., Cardoso, M.J., Carey, L.A., Dawood, S., Del Mastro, L., Denkert, C., Fallenberg, E.M., Francis, P.A., Gamal-Eldin, H., Gelmon, K., Geyer, C.E., Gnant, M., Guarneri, V., Gupta, S., Kim, S.B., Krug, D., Martin, M., Meattini, I., Morrow, M., Janni, W., Paluch-Shimon, S., Partridge, A., Poortmans, P., Pusztai, L., Regan, M.M., Sparano, J., Spanic, T., Swain, S., Tjulandin, S., Toi, M., Trapani, D., Tutt, A., Xu, B., Curigliano, G., Harbeck, N.

Volltext

CYP2C83 increases risk of neuropathy in breast cancer patients treated with paclitaxel von Hertz, D.L., Roy, S., Motsinger-Reif, A.A., Drobish, A., Clark, L.S., McLeod, H.L., Carey, L.A., Dees, E.C.

Volltext

Human brown adipose tissue as a target for obesity management; beyond cold‐induced thermogenesis von Loh, R.K.C., Kingwell, B.A., Carey, A.L.

Volltext

Homologous recombination deficiency and host anti-tumor immunity in triple-negative breast cancer von Telli, M. L., Stover, D. G., Loi, S., Aparicio, S., Carey, L. A., Domchek, S. M., Newman, L., Sledge, G. W., Winer, E. P.

Volltext

Acute IL-6 treatment increases fatty acid turnover in elderly humans in vivo and in tissue culture in vitro von Petersen, E. W, Carey, A. L, Sacchetti, M, Steinberg, G. R, Macaulay, S. L, Febbraio, M. A, Pedersen, B. K

Volltext

Race, response to chemotherapy, and outcome within clinical breast cancer subtypes von Tichy, J. R., Deal, A. M., Anders, C. K., Reeder-Hayes, K., Carey, L. A.

Volltext

Novel pharmacological approaches to combat obesity and insulin resistance: targeting skeletal muscle with 'exercise mimetics' von Carey, A. L, Kingwell, B. A

Volltext

Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Tria... von Freedman, Rachel A., Seisler, D. K., Foster, J. C., Sloan, J. A., Lafky, J. M., Kimmick, G. G., Hurria, A., Cohen, H. J., Winer, E. P., Hudis, C. A., Partridge, A. H., Carey, L. A., Jatoi, A., Klepin, H. D., Citron, M., Berry, D. A., Shulman, L. N., Buzdar, A. U., Suman, V. J., Muss, H. B.

Volltext

Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer von Bardia, A., Tolaney, S.M., Punie, K., Loirat, D., Oliveira, M., Kalinsky, K., Zelnak, A., Aftimos, P., Dalenc, F., Sardesai, S., Hamilton, E., Sharma, P., Recalde, S., Gil, E.C., Traina, T., O’Shaughnessy, J., Cortes, J., Tsai, M., Vahdat, L., Diéras, V., Carey, L.A., Rugo, H.S., Goldenberg, D.M., Hong, Q., Olivo, M., Itri, L.M., Hurvitz, S.A.

Volltext

Tucatinib versus placebo added to trastuzumab and capecitabine for patients with pretreated HER2+ metastatic breast cancer with and without brain metastases (HER2CLIMB): final over... von Curigliano, G., Mueller, V., Borges, V., Hamilton, E., Hurvitz, S., Loi, S., Murthy, R., Okines, A., Paplomata, E., Cameron, D., Carey, L.A., Gelmon, K., Hortobagyi, G.N., Krop, I., Loibl, S., Pegram, M., Slamon, D., Ramos, J., Feng, W., Winer, E.

Volltext

Non-steroidal anti-inflammatory drug use, hormone receptor status, and breast cancer-specific mortality in the Carolina Breast Cancer Study von Allott, E. H., Tse, C.-K., Olshan, A. F., Carey, L. A., Moorman, P. G., Troester, M. A.

Volltext

Interleukin-6 and tumor necrosis factor-α are not increased in patients with Type 2 diabetes: evidence that plasma interleukin-6 is related to fat mass and not insulin responsivene... von CAREY, A. L, BRUCE, C. R, SACCHETTI, M, ANDERSON, M. J, OLSEN, D. B, SALTIN, B, HAWLEY, J. A, FEBBRAIO, M. A

Volltext

Prognostic value of intrinsic subtypes in hormone-receptor-positive metastatic breast cancer: systematic review and meta-analysis von Schettini, F., Martínez-Sáez, O., Falato, C., De Santo, I., Conte, B., Garcia-Fructuoso, I., Gomez-Bravo, R., Seguí, E., Chic, N., Brasó-Maristany, F., Paré, L., Vidal, M., Adamo, B., Muñoz, M., Pascual, T., Ciruelos, E., Perou, C.M., Carey, L.A., Prat, A.

Volltext

ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer von Tarantino, P., Viale, G., Press, M.F., Hu, X., Penault-Llorca, F., Bardia, A., Batistatou, A., Burstein, H.J., Carey, L.A., Cortes, J., Denkert, C., Diéras, V., Jacot, W., Koutras, A.K., Lebeau, A., Loibl, S., Modi, S., Mosele, M.F., Provenzano, E., Pruneri, G., Reis-Filho, J.S., Rojo, F., Salgado, R., Schmid, P., Schnitt, S.J., Tolaney, S.M., Trapani, D., Vincent-Salomon, A., Wolff, A.C., Pentheroudakis, G., André, F., Curigliano, G.

Volltext

5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5) von Cardoso, F., Paluch-Shimon, S., Senkus, E., Curigliano, G., Aapro, M.S., André, F., Barrios, C.H., Bergh, J., Bhattacharyya, G.S., Biganzoli, L., Boyle, F., Cardoso, M.-J., Carey, L.A., Cortés, J., El Saghir, N.S., Elzayat, M., Eniu, A., Fallowfield, L., Francis, P.A., Gelmon, K., Gligorov, J., Haidinger, R., Harbeck, N., Hu, X., Kaufman, B., Kaur, R., Kiely, B.E., Kim, S.-B., Lin, N.U., Mertz, S.A., Neciosup, S., Offersen, B.V., Ohno, S., Pagani, O., Prat, A., Penault-Llorca, F., Rugo, H.S., Sledge, G.W., Thomssen, C., Vorobiof, D.A., Wiseman, T., Xu, B., Norton, L., Costa, A., Winer, E.P.

Volltext

No evidence of white adipocyte browning after endurance exercise training in obese men von Tsiloulis, T, Carey, A L, Bayliss, J, Canny, B, Meex, R C R, Watt, M J

Volltext

Risk-adapted modulation through de-intensification of cancer treatments: an ESMO classification von Trapani, D., Franzoi, M.A., Burstein, H.J., Carey, L.A., Delaloge, S., Harbeck, N., Hayes, D.F., Kalinsky, K., Pusztai, L., Regan, M.M., Sestak, I., Spanic, T., Sparano, J., Jezdic, S., Cherny, N., Curigliano, G., Andre, F.

Volltext

Leveraging existing data to contextualize phase II clinical trial findings in oncology von Ray, E.M., Carey, L.A., Reeder-Hayes, K.E.

Volltext